Our mission

We invest philanthropic capital in early-stage companies advancing transformative health solutions. Our regenerative model recycles investment returns into future innovations, helping more patients access the care they need.

Funding the hard stuff

Early-stage health innovations need patient capital to move forward. CIF backs overlooked solutions and supports founders as they bring new technologies closer to patients.

Three Verticals. Lasting Impact.

We fund innovation where unmet health needs meet persistent funding gaps.

The Need

  • >90%

    of rare diseases have
    no FDA-approved treatment

  • 1%

    of R&D spending goes to women’s health conditions, outside of cancer

  • 6

    new drugs approved to treat pediatric cancer in the last 40 years vs. 160 for adult cancer

  • .0001%

    of health innovations make it
    out of the lab and to the
    bedside of patients

  • 400K

    children are diagnosed with cancer each year worldwide

  • 80%

    of youth who need
    mental health treatment are
    not able to access it

  • 9%

    of high school students
    have attempted suicide

How catalytic capital works

How we invest

Donors empower impact

Our donors help bring new health solutions closer to patients. We match philanthropic capital with early-stage companies tackling persistent unmet needs.

Catalytic capital

We invest early, helping founders advance their technologies, strengthen operations, and attract additional investment. When companies generate returns, we reinvest that capital in future health innovations.

Backing women-led teams

We actively seek women-led companies developing transformative health technologies. Supporting diverse founders expands the ideas, experience, and solutions shaping the future of care.